Optimizing Clinical Endpoints in Neuroimmunology Drug Development: Bridging the Gap from Preclinical Promise to Clinical Success
Time: 8:35 am
day: Pre-Conference Day AM Track A
Details:
In the evolving field of neuroimmunology, defining and validating clinical endpoints is crucial for translating preclinical findings into successful therapies. This workshop will focus on the strategic selection and application of clinical endpoints to accurately assess efficacy and safety in neuroimmunology drug development. Participants will explore how to align endpoints with the unique challenges of neuroinflammatory diseases, ensuring they reflect meaningful clinical outcomes and patient benefits. The workshop will also address how innovative biomarkers and multi-modal data integration can enhance endpoint selection and interpretation.
Key Takeaways:
- End Point Selection Strategies: Learn best practices for choosing and validating clinical endpoints that align with disease mechanisms and therapeutic goals in neuroimmunology.
- Innovative Biomarkers Integration: Understand how emerging biomarkers, including imaging, proteomics, and genomics, can inform and refine clinical endpoints to provide more precise assessments of drug efficacy and safety.
- Data Interpretation and Translation: Gain insights into interpreting complex multi-modal data and translating preclinical results into relevant clinical outcomes, improving the likelihood of regulatory approval and clinical success
